Fish Oil and the Management of Hypertriglyceridemia

Рыбий жир и лечение гипертриглицеридемии
Mohab Mattar, Omar Obeid
2009-01-01

ApoE genotypedocosahexaenoic acid (DHA)eicosapentaenoic acid (EPA)hypertriglyceridemiaomega-3 fatty acids
Hypertriglyceridemia, regarded as one of the independent clinical markers of metabolic syndrome, is a frequently observed disorder that has been shown to be common in the Arab region. Epidemiologic and clinical trials demonstrated that omega-3 fatty acids have the potential to reduce the incidence of cardiovascular disease (CVD); one of the mechanisms by which this effect is achieved is through reducing plasma triglyceride levels. There is strong scientific evidence from human trials that omega-3 fatty acids from either fish or fish oil supplements significantly reduce blood triglyceride levels and these benefits appear to be dose-dependent. The active ingredients of fish oils include the long chain fatty acids EPA and DHA. The ideal amount of omega-3 fatty acid that should be incorporated into the diet without provoking detrimental effects on other lipid components such as decreasing HDL-C and/or increasing LDL-C has not yet been elucidated. Presently, a prescription form of omega-3 fatty acid has been approved by the United States Food and Drug Administration (USFDA) as an adjunct to the diet for the treatment of very high triglyceride levels (> or = 500 mg/dl) in adults. Patients with hypertriglyceridemia have been shown to respond well to the use of omega-3 fatty acids even when used in conjunction with statins where greater improvements in the lipid profile were found as compared to treatment with statins alone. A determinant of the responsiveness to fish oil could be attributed to the ApoE genotype of individuals.
1
EPA and DHA are the principal active long-chain fatty acids in fish oil responsible for its triglyceride-lowering effects.
2
Omega-3 fatty acids can improve lipid profiles beyond statin therapy alone, and responsiveness may vary according to an individual’s ApoE genotype.
3
Omega-3 fatty acids from fish or fish-oil supplements significantly reduce blood triglyceride levels in human trials, with benefits appearing dose-dependent.
4
The USFDA has approved prescription omega-3 fatty acids as an adjunct to diet for adults with very high triglycerides (≥500 mg/dl).
5
The optimal omega-3 dose remains uncertain because treatment may adversely affect other lipid components, including HDL-C and LDL-C.

Fish oil and omega-3 fatty acid supplementation in adults with hypertriglyceridemia

Dose-dependent reduction of plasma triglycerides and associated lipid-profile effects, including responsiveness by ApoE genotype and use with statins

Publication Details
Publication Date
2009-01-01
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Mohab Mattar
Omar Obeid
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%